An In-Cell Framework for Small Molecule Targeting of Human mRNAs
Time: 2:15 pm
day: Conference Day Two
Details:
- Built from the ground up, recognizing that RNA is a fundamentally different kind of drug target
- Has identified high-quality chemical matter against hundreds of high-value targets
- Solves challenges of selectivity and progressibility that have bedeviled RNA targeting
- Leads to rapid de-risking of targets, asset identification, and function modulation